HomeCompareTWAPF vs CL

TWAPF vs CL: Dividend Comparison 2026

TWAPF yields 2.78% · CL yields 4.00%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TWAPF wins by $74.3K in total portfolio value· pulled ahead in Year 2
10 years
TWAPF
TWAPF
● Live price
2.78%
Share price
$16.83
Annual div
$0.47
5Y div CAGR
42.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$102.3K
Annual income
$34,039.47
Full TWAPF calculator →
CL
CL
● Live price
4.00%
Share price
$50.00
Annual div
$2.00
5Y div CAGR
5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.0K
Annual income
$899.19
Full CL calculator →

Portfolio growth — TWAPF vs CL

📍 TWAPF pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTWAPFCL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TWAPF + CL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TWAPF pays
CL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TWAPF
Annual income on $10K today (after 15% tax)
$236.32/yr
After 10yr DRIP, annual income (after tax)
$28,933.55/yr
CL
Annual income on $10K today (after 15% tax)
$340.00/yr
After 10yr DRIP, annual income (after tax)
$764.31/yr
At 15% tax rate, TWAPF beats the other by $28,169.24/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TWAPF + CL for your $10,000?

TWAPF: 50%CL: 50%
100% CL50/50100% TWAPF
Portfolio after 10yr
$65.2K
Annual income
$17,469.34/yr
Blended yield
26.80%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CL right now

TWAPF
No analyst data
Altman Z
1.9
Piotroski
6/9
CL
Analyst Ratings
17
Buy
24
Hold
2
Sell
Consensus: Hold
Price Target
$92.45
+84.9% upside vs current
Range: $85.00 — $100.00
Altman Z
4.5
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TWAPF buys
0
CL buys
9
PoliticianChamberTickerTypeAmountDate
John Boozman🏛 Senate$CL▼ Sell$1,001 - $15,0002025-10-09
Ro Khanna🏢 House$CL▼ Sell$1,001 - $15,0002025-10-07
Rick Larsen🏢 House$CL▼ Sell$1,001 - $15,0002025-10-06
Ro Khanna🏢 House$CL▼ Sell$1,001 - $15,0002025-09-29
Julie Johnson🏢 House$CL▼ Sell$1,001 - $15,0002025-09-25
Lisa McClain🏢 House$CL▼ Sell$1,001 - $15,0002025-09-11
Tim Moore🏢 House$CL▼ Sell$1,001 - $15,0002025-09-10
Ro Khanna🏢 House$CL▲ Buy$1,001 - $15,0002025-09-05
Ro Khanna🏢 House$CL▲ Buy$1,001 - $15,0002025-08-26
Lisa McClain🏢 House$CL▲ Buy$1,001 - $15,0002025-08-13
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTWAPFCL
Forward yield2.78%4.00%
Annual dividend / share$0.47$2.00
Payout ratio50%50%
1-year div growth0%5%
5-year div CAGR42.8%5%
Portfolio after 10y$102.3K$28.0K
Annual income after 10y$34,039.47$899.19
Total dividends collected$75.0K$6.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: TWAPF vs CL ($10,000, DRIP)

YearTWAPF PortfolioTWAPF Income/yrCL PortfolioCL Income/yrGap
1$11,097$397.02$11,120$420.00$23.00CL
2← crossover$12,462$587.99$12,357$458.31+$105.00TWAPF
3$14,215$881.22$13,721$499.76+$494.00TWAPF
4$16,552$1,341.55$15,227$544.58+$1.3KTWAPF
5$19,795$2,084.70$16,885$593.02+$2.9KTWAPF
6$24,508$3,327.36$18,713$645.34+$5.8KTWAPF
7$31,722$5,497.89$20,724$701.81+$11.0KTWAPF
8$43,439$9,496.96$22,938$762.73+$20.5KTWAPF
9$63,836$17,356.18$25,372$828.41+$38.5KTWAPF
10$102,344$34,039.47$28,047$899.19+$74.3KTWAPF

TWAPF vs CL: Complete Analysis 2026

TWAPFStock

Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan. The company provides its products in the therapeutic areas of diabetes, digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products. It had a portfolio of approximately 700 drug products. Towa Pharmaceutical Co., Ltd. was founded in 1951 and is headquartered in Osaka, Japan.

Full TWAPF Calculator →

CLConsumer Staples

CL is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in CL shares.

Full CL Calculator →
📬

Get this TWAPF vs CL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TWAPF vs SCHDTWAPF vs JEPITWAPF vs OTWAPF vs KOTWAPF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.